effect of semaglutide on chronic kidney disease Cardio-kidney-metabolic protective effects across the spectrum of Patients with type 2 #diabetes
Description
(2024b)
from the University of Arizona
It is indicated for blood sugar control in patients with type 2 diabetes mellitus, either as a monotherapy or in combination with other glucose-lowering drugs
Learn more about GLP-1 candidacy Considerations for Use These medications are most effective when combined with a healthy diet and regular exercise
mTOR links incretin signaling to HIF induction in pancreatic beta cells
